Printer Friendly

Articles from M2 Pharma (April 18, 2018)

1-28 out of 28 article(s)
Title Author Type Words
Advent International to acquire Sanofi's European generics business. 161
Advent International to acquire Zentiva. 137
Alliance Pharmaceuticals to sell 60% interest in Unigreg. 180
Alligator Bioscience announces presentation ATOR-1015 preclinical data at the AACR Annual Meeting 2018. 240
Alnylam Study of Givosiran for Treatment of Acute Hepatic Porphyrias Demonstrates Lowering of Urinary ALA and Decrease in Porphyria Attack Rate. 268
American Skin Association names board member Luigi L. De Ghenghi. 168
American Skin Association welcomes new board member Emma Guttman. 188
Astellas Grants Exclusive License to Cardurion Pharmaceuticals to Develop Clinical Stage Heart Failure Candidate. 235
Avita Trial of Recell Device Demonstrates Reduction in Donor Skin Requirements in Third-Degree Burns. 222
Boehringer announces US FDA full approval for first and only specific reversal agent for novel oral anticoagulant Praxbind. 280
Boehringer Ingelheim and Eli Lilly sign academic collaboration with Oxford University. 196
Bristol-Myers Squibb Partners with Illumina to Develop Diagnostic Oncology Assay to Measure Predictive Genomic Biomarkers. 250
Clovis Oncology Initiates Public Offerings of Convertible Senior Notes and Common Stock. 350
Data on Multiple Investigational Regimens for Treatment of NASH and Advanced Fibrosis Presented by Gilead at 2018 International Liver Congress. 227
Dermavant Sciences adds four new members to executive team. 234
emotive names new senior account director. 117
FDA Accepts for Filing Eagle Pharmaceuticals ANDA for Vasopressin. 148
Genentech Data Demonstrate Efficacy, Safety, and Benefits of Ocrevus in Relapsing and Primary Progressive MS. 224
Genmab to receive royalties on net sales of USD432m for DARZALEX in Q1 2018. Financial report 220
Ketamine could become a new drug for depression, study suggests. Clinical report 664
King-Devick technologies passes US FDA clearance for K-D Balance App. 236
Medical Microinstruments raises EUR20m in Series A funding. 238
Medical Microinstruments SpA closes EUR20m Series A financing. 173
Navidea to Sublicense NAV4694 to Cerveau Technologies Subsidiary Meilleur. 368
Orphazyme establishes US subsidiary in Massachusetts. 211
PhoreMost Partners with Daiichi Sankyo Subsidiary Plexxikon to Identify Novel Drug Targets. 208
Rigel Pharmaceuticals Inc wins US FDA approval for TAVALISSE for treating chronic immune thrombocytopenia in adult patients. 282
The US Food and Drug Administration awards approval for Crysvita for rare inherited form of rickets, x-linked hypophosphatemia. 299

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |